US3698398A - Rate-scanning pacer for treatment of tachycardia - Google Patents
Rate-scanning pacer for treatment of tachycardia Download PDFInfo
- Publication number
- US3698398A US3698398A US87387A US3698398DA US3698398A US 3698398 A US3698398 A US 3698398A US 87387 A US87387 A US 87387A US 3698398D A US3698398D A US 3698398DA US 3698398 A US3698398 A US 3698398A
- Authority
- US
- United States
- Prior art keywords
- heart
- pacer
- patient
- rate
- recited
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102100026827 Protein associated with UVRAG as autophagy enhancer Human genes 0.000 title claims abstract description 37
- 101710102978 Protein associated with UVRAG as autophagy enhancer Proteins 0.000 title claims abstract description 37
- 238000011282 treatment Methods 0.000 title abstract description 10
- 208000001871 Tachycardia Diseases 0.000 title description 10
- 230000006794 tachycardia Effects 0.000 title description 10
- 230000004936 stimulating effect Effects 0.000 claims abstract description 5
- 235000014676 Phragmites communis Nutrition 0.000 claims description 13
- 230000007423 decrease Effects 0.000 claims description 13
- 230000003247 decreasing effect Effects 0.000 claims description 7
- 239000003990 capacitor Substances 0.000 abstract description 53
- 210000002837 heart atrium Anatomy 0.000 abstract description 7
- 206010047302 ventricular tachycardia Diseases 0.000 abstract description 6
- 238000007599 discharging Methods 0.000 abstract description 3
- 230000010355 oscillation Effects 0.000 description 10
- 230000007246 mechanism Effects 0.000 description 6
- 230000000638 stimulation Effects 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 208000003734 Supraventricular Tachycardia Diseases 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 230000002861 ventricular Effects 0.000 description 4
- 230000001746 atrial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000004962 physiological condition Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 206010003668 atrial tachycardia Diseases 0.000 description 2
- 206010061592 cardiac fibrillation Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002600 fibrillogenic effect Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000005245 right atrium Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000034053 Accessory Atrioventricular Bundle Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001326 carotid sinus Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 208000008510 paroxysmal tachycardia Diseases 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000001013 sinoatrial node Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/3621—Heart stimulators for treating or preventing abnormally high heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/37—Monitoring; Protecting
Definitions
- the pacer comprises terminals for connection 'to the heart, a controllable electrical stimuli generator controlled internally by a discharging capacitor and controlled externally by a magnet.
- the pacer is particularly applicable to the treatment of paroxysmal supra-ventricular tachycardias, a rapid heartbeat condition originating in the atrium.
- the pacer can be temporarily activated by the patient.
- the present invention relates in general to electrical pacing of a heart. More particularly, the present invention relates to electrical stimulation of the atria or ventricles of the heart for treating paroxysmal supra-ventricular tachycardia.
- the PQRST wave form complex depicted by electrocardiograms is well known in the electro-medical art.
- the QRS portion of the wave form complex is associated with the ventricular action of the heart.
- the P- wave. is associated with the atrial action of the heart.
- a typical frequency of occurrence of the wave form complex,or heartbeat rate, when the patient is at rest, is in the neighborhood of 70 times per minute.
- the frequency of occurrence of the wave form complex, due to improper heart functioning can exceed 160 occurrences per minute.
- This excessive rapidity of the hearts action is known as Tachycardia.
- the physiological range with regard to normal heartbeat rate can vary considerably between individuals. For example, a child can have a normal physiological range comprises of heartbeat rates considerably higher than those of an adult.
- Atrial tachycardia is the medical term assigned to the condition in which rapid and regular succession of P-waves of the wave form complex occur. The rate of occurrence is in excess of the physiological range implantable terminals or electrodes. The the particular patient.
- Paroxysmal supra-ventricular tachycardia is the medical term assigned to the condition in which there is a sudden attack of rapid heart action in the atria or in the atrial-ventricular node. The main characteristics are the same as those in atrial tachycardia.
- the electrical activity begins with a nerve impulse generated by a bundle of fibers located in the sino-atrial node.
- the impulse spreads across the two atria while they contract and speed the flow of blood into the ventricle underneath them.
- the electrical impulse continues to spread across the atrial-ventricular node, which in turn stimulates the left and right ventricle.
- tachycardia can arise when peculianunique conditions occur unpredictably.
- These conditions are associated with geometry of the atria, location of the nerve impulse, timing of the beat and impulse conduction velocity within the cardiac tissue. These conditions can set up a re-entry mechanism in the atria, for example, whereby the impulse continues to self-perpetuate.
- the self-perpetuation occurs at a rate above the physiological rate and is self-sustaining even after the unique. condition, (which permitted it to start), no longer exists.
- the self-perpetuation must then be interrupted by outside intervention interfering with the re-entry mechanism, thus permitting the heart to resume normal sequence.
- the self-perpetuation can be interrupted by electrical stimulation occurring at a critical time interval that is dependent on the patients physiological condition at that time.
- the critical interval required is not predictable.
- the stimuli could be applied to a ventricle.
- the stimuli were generated at a rate above the normal physiological heartbeat rate range. In particular embodiment, the stimuli were generated at a rate in the neighborhood of 1,000 per minute for a period of approximately 5 seconds duration. This amounts to individual bursts of approximately 83 pulses. Thus, some of the stimuli in the burst are properly spaced from each other to satisfy the critical interval.
- the high repetition rate burst cannot be applied to all patients.
- the ventricle could respond to many of the fast stimuli, and produce a fast ventricular rate.
- a high repetition rate burst of stimuli is dangerous and could result in fibrillation. Fibrillation can be fatal.
- the present invention is a therapeutic solution for these patients.
- the present invention relates to a repetition rate scanning pacer that could be within the normal physiological rate range.
- the scanning pacer changes the interval between successive stimuli in a progressive manner.
- One of the increasing (or decreasing) intervals in the succession of intervals is expected to be the critical interval that will allow interruption of the parox ysmal tachycardia mechanism.
- the repetitionrate range can lie within the normal physiological rate range (i.e., 50 to stimuli per minute) there is no danger to patients with abnormal passways.
- the pacer has no distinct rate.
- the present invention relates to an externally activated implantable heart pacer for providing a series of stimulating pulses to the heart of a patient to treat a condition of tachycardia.
- the present invention incorporates an electrical stimuli generator and a control for controlling the generator.
- the stimuli are conducted to the heart via implantable terminals or electrodes
- the control incorporates an external magnet and an implanted magnetic reed switch.
- Advantages of the present invention include immediate and self-initiated treatment.
- the patient can sense when tachycarida occurs by his dizziness, perspiration and weakness. The patient can recognize these symptoms readily. Instead of going to a hospital for treatment, as is usually necessary at present, the patient can apply stimulation himself via an externally controlled implanted stimulator.
- FIG. 1 is a block diagram of an illustrative embodiment of the present invention, indicating the implantable stimulator and external magnet;
- FIG. 2 is a schematic diagram of the circuit of an illustrative embodiment of the present invention.
- FIG. 1 a functional block diagram of an illustrative embodiment of the present invention is depicted.
- - Oscillator control 11 controls oscillator 12 as shown.
- Oscillator l2 triggers stimuli pulse generator 13 once with each oscillation.
- Stimuli pulse generator 13 provides an electrical stimulus to heart 14 with each oscillation.
- Heart 14 is stimulated in response thereto.
- Control 1 1, oscillator 12, generator 13, and heart 14 are depicted as enclosed by phantom line 10. Phantom line is intended to represent the surface of a patient in whom the stimulator is implanted.
- Magnet 15 is depicted as external to the patient. It is positioned in close proximity to the oscillator control 11, and dashed line 16 is intended to indicate the dependence of oscillator control 11 on magnet 15.
- FIG. 2 is a circuit diagram of an illustrative embodiment of the present invention.
- Batteries 3 through 7 are connected in series aiding. (The dashed line between batteries 3 and 7 indicate that the exact number of batteries used may vary.)
- the positive terminal of battery 7 is connected to the junction of one end of resistor 23 and one end of resistor 24.
- the negative terminal of battery 3 is connected to a junction comprised of one side of capacitor 28, the emitter of transistor T9, electrode E2, one end of resistor 25, and one end of resistor 63.
- the other end of resistor 23 is connected to terminal 30 of reed switch 32.
- Reed element 31 makes contact with terminal 30 in the normally closed position, and connects terminal 30 with the other side of capacitor 28.
- Terminal 29 is the normally open contact of reed switch 32, and is connected to the junction consisting of one end of resistor 35 and the anode of diode 27.
- the cathode of diode 27 is connected to the anode of diode 26 whose cathode is connected to a junction comprised of resistor 25, the base of transistor T7, and
- the other end of resistor 37 is connected to one side of capacitor 57 the other side being connected to a junction consisting of the emitter of transistor T8 and one end of resistor 61.
- the other end of resistor 61 is connected to a junction comprised of the other end of resistor 63 and the base of transistor T9.
- the collector of transistor T9 is connected to a junction comprised of the other end of resistor 24, and one side of capacitor 65.
- the other side of capacitor 65 is connected to electrode El. Electrodes E1 and E2 are both connected to heart 14.
- capacitor 28 charges to a value of voltage equal to the sum of potentials of the batteries or to full battery voltage.
- the charging circuit includes resistor 23, the contact made between terminal 30 and reed element 31, and capacitor 28.
- capacitor 65 When reed element 31 is in the position depicted, there is no energization provided to the circuitry to the left of capacitor 28. Thus, transistor T9 is non-conducting because of zero base current and T9 behaves like an open switch. The open switch maintains capacitor 65 charged to full battery voltage. Resistor 24, capacitor 65, electrode El, heart 14, electrode E2 and the conductive path returning to the negative terminal of battery 3 comprise a charge path for capacitor 65. Capacitor 65 charges through the heart. The relatively slow charging of capacitor 65, (due to resistor 24,) through the heart does not cause any stimulation to the heart. (It is the rapid discharge of capacitor 65, to be described later, which provides stimulation to the heart.)
- the charged capacitor is an unusual DC. power supply in the sense that its output voltage is a decreasing function of time rather than a fixed function of time. Thus, at some predetermined time during discharge of capacitor 28 through the circuitry to its left, the capacitor voltage will fall below some predetermined voltage that is required to maintain operation of the circuitry to its left.
- the series circuit of diode 27, 26 and resistor 25 establish a biasing network for transistor T7 and T8.
- Current flow from capacitor 28 through both diodes and resistor 25 establish a potential at the cathode of diode 26 that is approximately 1 volt less than voltage at the anode of diode 27.
- This voltage difference is due to the forward voltage drop of diodes 26 and 27 being approximately 0.5 volts each and being approximately constant for different forward current values. There is nothing unique about 1.0 volts. An approximately constant 1.2 volts would work equally well.
- the actual value of voltage drop is a function of the diodes employed, (As voltage on capacitor 28 decreases, current through resistor 25 decreases but the l-volt drop across the diodes remains approximately constant.)
- This voltage at the cathode of diode 26 is a threshold voltage which must be exceeded by voltage at the emitter of transistor T7 by approximately 0.5 volts (since the base-emitter junction of transistor T7 requires a forward bias voltage similar to the 0.5 volt drop of the diodes) before transistor T7 and T8 conduct.
- Capacitor 57 charges through resistors 35 and 37 until the voltage across it causes transistors T7 and T8 to conduct.
- the emitter electrode of transistor T7 goes sufficiently positive to exceed threshold voltage at the base of transistor T7 by approximately 0.5 volts, the transistors conduct and current flows through the emitter circuit of transistor T8. Current coming from both capacitors 28 and 57 continues to flow through the emitter of transistor T8 until the potential difference between the emitter and base of transistor T7 drops below approximately 0.5 volts due to sufficient discharge of capacitor 57. Note that the current drain from capacitor 28 during this operation contributes to its discharge.
- capacitor 57 is made to charge from the value of voltage across it at the time of turn off of these transistors toward a new (and lower) value of voltage on capacitor 28.
- transistors T7 and T8 conduct once again and the cycle is repeated.
- This circuitry comprises an oscillator and can be thought of as a type of relaxation oscillator.
- the frequency of this particular oscillator increases with each cycle of oscillation (or the time interval between each stimuli pulse decreases with each cycle).
- the oscillator has no distinct rate.
- the reason for this decrease of interval with each cycle is due to unequal rates of voltage decrease at the base and at the emitter of transistor T7.
- the voltage drop across diodes 27 and 26 are approximately constant and the voltage at the cathode of diode 26 (the base of T7) decreases at the same rate as the voltage decrease on capacitor 28.
- the voltage at the emitter of transistor T7 decreases at a slower rate due to voltage divider action of resistors 35 and 37.
- the base and. emitter voltages of transistor T7 both decease as capacitor 28 discharges, the base voltage decreases faster.
- transistor T7 returns to a conducting state sooner due to earlier forward biasing of its base-emitter junction with each cycle.
- Capacitor 57 charge time is primarily determined by resistors 35 and 37; its discharge time is primarily determined by resistor 37.
- Resistors 35 and 37 are in the charge path of capacitor 57 but only resistor 37 is in the discharge path.
- capacitor 28 With each oscillation, the power supply voltage provided by capacitor 28 is decreased in value. Thus after a predetermined period of time, capacitor 28 will run down to a predetermined voltage and there will be insufficient energy stored in capacitor 28, in view of the biasing constraints imposed by its load circuitry, to provide another single oscillation. At this point, there will be no further energizations supplied to the heart unless capacitor 28 is recharged.
- the number of oscillations can be controlled or limited by removing the magnet prior to discharge of capacitor 28 to the predetermined voltage.
- Transistor T9 is a simple current amplifier which is normally non-conducting. When transistor T8 conducts the emitter current flowing through resistors 61 and 63 causes the potential at the base of transistor 59 to increase.
- transistor T9 is biased to conduction and capacitor 65 can discharge through it through the heart.
- Capacitor 65 discharges more rapidly than it charges since resistor 24 is not involved in the discharge path.
- Capacitor 65 discharges through an essentially short circuited transistor switch.
- Transistor T9 operates in response to each oscillation. The combination of the oscillator, transistor T9, and capacitor 65 comprise a pulse generator.
- the frequency (repetition-rate) range can be made as large as desired. It can be made to scan through a wide range from below the physiological rate range to above the physiological rate range. However, for a patient with abnormal passways, the range is limited to within the physiological rate range of that patient. A typical rate range would be 90 to 130 cycles per minute.
- reed switch 32 assumes the depicted state.
- Capacitor 28 is recharged and capacitor 65 is recharged as previously described. Only if the patient or another person places magnet 15 in proper position once again will there be another burst of stimuli to the heart. The patient can perform this operation himself in response to an uncomfortable feeling when he goes into tachycardia. (Paroxysmal supraventricular tachycardia is a disorder which is not lethal but which does cause temporary discomfort to the patient.) When the magnet is in position once again, capacitor 28 assumes its role as power supply and once again a burst of stimuli is applied to the heart.
- the decreasing intervals in the'second burst will not correspond exactly in duration to the decreasing intervals in the first burst.
- This difference (although slight) is attributed to variations in the semiconductors due to some self-heating, and to variations in the amounts residual voltage on the capacitors.
- This change in corresponding intervals between bursts is usually desirable as it can result in a greater liklihood of the critical interval occurring during the second burst.
- the patients critical interval requirements may vary between bursts, i.e., the critical interval required by the patient can vary from burst to burst which can further enhance the chance of the pulse generators supplying pulses at the critical interval.
- the oscillator need not be of the relaxation variety, the output could be transformer coupled, and other means for controlling turn on and turn off of the oscillator could be employed. It should be understood that other biasing arrangements could be used so that the frequency of oscillation could decrease instead of increase, and could even randomly increase or decrease.
- the essential requirement is to cause the critical interval to occur.
- the present invention can, of course, be extra corporeal (external) having the terminals implanted or the entire mechanism, with the exception of the control, can be implanted.
- a heart pacer for stimulating the heart of a patient, said pacer comprising terminal means for connection to the heart of said patient, pulse generator means for generating electrical stimuli on said terminal means at a varying repetition rate within the normal physiological heartbeat rat -r nge of said patient, sai d pu se generator means 1110 u ing means for automatically maintaining each interval between stimuli different in duration from the next most previous interval and from the next successive interval.
- a heart pacer as recited in claim 1 further comprising control means for controlling duration of operation of said pulse generator means.
- control means comprises a reed switch and a magnet, the field of said magnet arranged to operate said switch.
- a heart pacer as recited in claim 1 further including a self varying source of voltage and said pulse generator being energized by said self-varying source of voltage.
- control means includes automatic means for automatically terminating the generation of said stimuli after a predetermined time.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
Claims (8)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8738770A | 1970-11-06 | 1970-11-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3698398A true US3698398A (en) | 1972-10-17 |
Family
ID=22204883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US87387A Expired - Lifetime US3698398A (en) | 1970-11-06 | 1970-11-06 | Rate-scanning pacer for treatment of tachycardia |
Country Status (1)
Country | Link |
---|---|
US (1) | US3698398A (en) |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0016574A1 (en) * | 1979-03-07 | 1980-10-01 | Siemens-Elema AB | Pacemaker for tachycardia control |
WO1980002498A1 (en) * | 1979-05-14 | 1980-11-27 | Medtronic Inc | Telemetry transmission system for analog and digital data from an implanted source |
FR2485929A1 (en) * | 1980-03-25 | 1982-01-08 | Telectronics Pty Ltd | DOUBLE IMPULSE ANTI-TACHYCARDIA STIMULATOR |
DE3110014A1 (en) * | 1980-05-19 | 1982-03-25 | Telectronics Pty. Ltd., Lane Cove, New South Wales | EXTERNALLY RESETTABLE TACHYCARDY REGULATOR PACEMAKER |
DE3110013A1 (en) * | 1981-03-11 | 1982-09-23 | Telectronics Pty. Ltd., Lane Cove, New South Wales | Rate-related tachycardia control pacemaker |
DE3115124A1 (en) * | 1981-04-10 | 1982-11-04 | Biotronik Meß- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin, 1000 Berlin | "HEART PACEMAKER" |
US4398536A (en) * | 1981-07-17 | 1983-08-16 | Telectronics Pty. Ltd. | Scanning burst tachycardia control pacer |
US4406287A (en) * | 1981-07-17 | 1983-09-27 | Telectronics Pty. Ltd. | Variable length scanning burst tachycardia control pacer |
EP0094758A2 (en) | 1982-05-03 | 1983-11-23 | Medtronic, Inc. | Tachyarrythmia pacer |
US4462407A (en) * | 1982-05-05 | 1984-07-31 | Cordis Corporation | Dual channel cardiac pacer isolation circuit |
US4577633A (en) * | 1984-03-28 | 1986-03-25 | Medtronic, Inc. | Rate scanning demand pacemaker and method for treatment of tachycardia |
USRE32361E (en) * | 1979-05-14 | 1987-02-24 | Medtronic, Inc. | Implantable telemetry transmission system for analog and digital data |
US4830006A (en) * | 1986-06-17 | 1989-05-16 | Intermedics, Inc. | Implantable cardiac stimulator for detection and treatment of ventricular arrhythmias |
US4884575A (en) * | 1987-12-08 | 1989-12-05 | Intermedics, Inc. | Cardiac pacer with patient-controlled exercise rate and method |
US5066272A (en) * | 1990-06-29 | 1991-11-19 | The Johns Hopkins University | Magnetic nerve stimulator |
US20060136005A1 (en) * | 2004-12-21 | 2006-06-22 | Ebr Systems, Inc. | Implantable transducer devices |
US20060136004A1 (en) * | 2004-12-21 | 2006-06-22 | Ebr Systems, Inc. | Leadless tissue stimulation systems and methods |
US20070060961A1 (en) * | 2005-09-12 | 2007-03-15 | Ebr Systems, Inc. | Methods and apparatus for determining cardiac stimulation sites using hemodynamic data |
US20070078490A1 (en) * | 2004-12-21 | 2007-04-05 | Ebr Systems, Inc. | Leadless tissue stimulation systems and methods |
US20080294208A1 (en) * | 2007-05-23 | 2008-11-27 | Ebr Systems, Inc. | Optimizing energy transmission in a leadless tissue stimulation system |
US7765001B2 (en) | 2005-08-31 | 2010-07-27 | Ebr Systems, Inc. | Methods and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices |
US7953493B2 (en) | 2007-12-27 | 2011-05-31 | Ebr Systems, Inc. | Optimizing size of implantable medical devices by isolating the power source |
US9283392B2 (en) | 2008-03-25 | 2016-03-15 | Ebr Systems, Inc. | Temporary electrode connection for wireless pacing systems |
US9731139B2 (en) | 2008-07-16 | 2017-08-15 | Ebr Systems, Inc. | Local lead to improve energy efficiency in implantable wireless acoustic stimulators |
US12023488B2 (en) | 2020-08-17 | 2024-07-02 | Ebr Systems, Inc. | Implantable stimulation assemblies having tissue engagement mechanisms, and associated systems and methods |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB985797A (en) * | 1962-11-24 | 1965-03-10 | Pye Ltd | Improvements in or relating to muscle stimulation devices |
US3195540A (en) * | 1963-03-29 | 1965-07-20 | Louis C Waller | Power supply for body implanted instruments |
US3209081A (en) * | 1961-10-02 | 1965-09-28 | Behrman A Ducote | Subcutaneously implanted electronic device |
US3253596A (en) * | 1963-05-27 | 1966-05-31 | Cordis Corp | Cardiac pacer |
FR1444363A (en) * | 1964-06-13 | 1966-07-01 | Presna Mechanika Narodny Podni | Installation for indirect control of control elements of implanted devices, for example in a living organism |
US3391697A (en) * | 1965-09-20 | 1968-07-09 | Medtronic Inc | Runaway inhibited pacemaker |
US3474353A (en) * | 1968-01-04 | 1969-10-21 | Cordis Corp | Multivibrator having pulse rate responsive to battery voltage |
US3517663A (en) * | 1968-04-15 | 1970-06-30 | Gen Electric | Threshold analyzer for an implanted heart stimulator |
-
1970
- 1970-11-06 US US87387A patent/US3698398A/en not_active Expired - Lifetime
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3209081A (en) * | 1961-10-02 | 1965-09-28 | Behrman A Ducote | Subcutaneously implanted electronic device |
GB985797A (en) * | 1962-11-24 | 1965-03-10 | Pye Ltd | Improvements in or relating to muscle stimulation devices |
US3195540A (en) * | 1963-03-29 | 1965-07-20 | Louis C Waller | Power supply for body implanted instruments |
US3253596A (en) * | 1963-05-27 | 1966-05-31 | Cordis Corp | Cardiac pacer |
FR1444363A (en) * | 1964-06-13 | 1966-07-01 | Presna Mechanika Narodny Podni | Installation for indirect control of control elements of implanted devices, for example in a living organism |
US3391697A (en) * | 1965-09-20 | 1968-07-09 | Medtronic Inc | Runaway inhibited pacemaker |
US3474353A (en) * | 1968-01-04 | 1969-10-21 | Cordis Corp | Multivibrator having pulse rate responsive to battery voltage |
US3517663A (en) * | 1968-04-15 | 1970-06-30 | Gen Electric | Threshold analyzer for an implanted heart stimulator |
Non-Patent Citations (2)
Title |
---|
Bilgutay et al., Journal of Thoracic & Cardiovascular Surgery, Vol. 56, No. 1, July 1968, pp 71 82 * |
Davies British Institute of Radio Engineers Journal Vol. 24, No. 6, December 1962, pp. 453 456 * |
Cited By (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0016574A1 (en) * | 1979-03-07 | 1980-10-01 | Siemens-Elema AB | Pacemaker for tachycardia control |
WO1980002498A1 (en) * | 1979-05-14 | 1980-11-27 | Medtronic Inc | Telemetry transmission system for analog and digital data from an implanted source |
US4281664A (en) * | 1979-05-14 | 1981-08-04 | Medtronic, Inc. | Implantable telemetry transmission system for analog and digital data |
USRE32361E (en) * | 1979-05-14 | 1987-02-24 | Medtronic, Inc. | Implantable telemetry transmission system for analog and digital data |
FR2485929A1 (en) * | 1980-03-25 | 1982-01-08 | Telectronics Pty Ltd | DOUBLE IMPULSE ANTI-TACHYCARDIA STIMULATOR |
US4408606A (en) * | 1980-05-19 | 1983-10-11 | Telectronics Pty. Ltd. | Rate related tachycardia control pacer |
DE3110014A1 (en) * | 1980-05-19 | 1982-03-25 | Telectronics Pty. Ltd., Lane Cove, New South Wales | EXTERNALLY RESETTABLE TACHYCARDY REGULATOR PACEMAKER |
DE3110013A1 (en) * | 1981-03-11 | 1982-09-23 | Telectronics Pty. Ltd., Lane Cove, New South Wales | Rate-related tachycardia control pacemaker |
US4412541A (en) * | 1981-04-10 | 1983-11-01 | Max Schaldach | Cardiac pacemaker |
DE3115124A1 (en) * | 1981-04-10 | 1982-11-04 | Biotronik Meß- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin, 1000 Berlin | "HEART PACEMAKER" |
US4406287A (en) * | 1981-07-17 | 1983-09-27 | Telectronics Pty. Ltd. | Variable length scanning burst tachycardia control pacer |
US4398536A (en) * | 1981-07-17 | 1983-08-16 | Telectronics Pty. Ltd. | Scanning burst tachycardia control pacer |
EP0094758A2 (en) | 1982-05-03 | 1983-11-23 | Medtronic, Inc. | Tachyarrythmia pacer |
US4462407A (en) * | 1982-05-05 | 1984-07-31 | Cordis Corporation | Dual channel cardiac pacer isolation circuit |
US4577633A (en) * | 1984-03-28 | 1986-03-25 | Medtronic, Inc. | Rate scanning demand pacemaker and method for treatment of tachycardia |
US4830006A (en) * | 1986-06-17 | 1989-05-16 | Intermedics, Inc. | Implantable cardiac stimulator for detection and treatment of ventricular arrhythmias |
US4884575A (en) * | 1987-12-08 | 1989-12-05 | Intermedics, Inc. | Cardiac pacer with patient-controlled exercise rate and method |
US5066272A (en) * | 1990-06-29 | 1991-11-19 | The Johns Hopkins University | Magnetic nerve stimulator |
US9333364B2 (en) | 2004-06-15 | 2016-05-10 | Ebr Systems, Inc. | Methods and systems for heart failure treatments using ultrasound and leadless implantable devices |
US20100286744A1 (en) * | 2004-06-15 | 2010-11-11 | Ebr Systems, Inc. | Methods and systems for heart failure treatments using ultrasound and leadless implantable devices |
US20090326601A1 (en) * | 2004-12-21 | 2009-12-31 | Ebr Systems, Inc. | Implantable transducer devices |
US7890173B2 (en) | 2004-12-21 | 2011-02-15 | Ebr Systems, Inc. | Implantable transducer devices |
US20060136005A1 (en) * | 2004-12-21 | 2006-06-22 | Ebr Systems, Inc. | Implantable transducer devices |
US7558631B2 (en) | 2004-12-21 | 2009-07-07 | Ebr Systems, Inc. | Leadless tissue stimulation systems and methods |
US7606621B2 (en) | 2004-12-21 | 2009-10-20 | Ebr Systems, Inc. | Implantable transducer devices |
US7610092B2 (en) | 2004-12-21 | 2009-10-27 | Ebr Systems, Inc. | Leadless tissue stimulation systems and methods |
US8315701B2 (en) | 2004-12-21 | 2012-11-20 | Ebr Systems, Inc. | Leadless tissue stimulation systems and methods |
US20100063562A1 (en) * | 2004-12-21 | 2010-03-11 | Ebr Systems, Inc. | Leadless tissue stimulation systems and methods |
US20070078490A1 (en) * | 2004-12-21 | 2007-04-05 | Ebr Systems, Inc. | Leadless tissue stimulation systems and methods |
US7996087B2 (en) | 2004-12-21 | 2011-08-09 | Ebr Systems, Inc. | Leadless tissue stimulation systems and methods |
US20100228308A1 (en) * | 2004-12-21 | 2010-09-09 | Ebr Systems, Inc. | Leadless tissue stimulation systems and methods |
US20060136004A1 (en) * | 2004-12-21 | 2006-06-22 | Ebr Systems, Inc. | Leadless tissue stimulation systems and methods |
US7848815B2 (en) | 2004-12-21 | 2010-12-07 | Ebr Systems, Inc. | Implantable transducer devices |
US9008776B2 (en) | 2004-12-21 | 2015-04-14 | Ebr Systems, Inc. | Leadless tissue stimulation systems and methods |
US10207115B2 (en) | 2005-08-31 | 2019-02-19 | Ebr Systems, Inc. | Method and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices |
US7765001B2 (en) | 2005-08-31 | 2010-07-27 | Ebr Systems, Inc. | Methods and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices |
US11376439B2 (en) | 2005-08-31 | 2022-07-05 | Ebr Systems, Inc. | Methods and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices |
US12133983B2 (en) | 2005-08-31 | 2024-11-05 | Ebr Systems, Inc. | Methods and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices |
US7702392B2 (en) | 2005-09-12 | 2010-04-20 | Ebr Systems, Inc. | Methods and apparatus for determining cardiac stimulation sites using hemodynamic data |
US20070060961A1 (en) * | 2005-09-12 | 2007-03-15 | Ebr Systems, Inc. | Methods and apparatus for determining cardiac stimulation sites using hemodynamic data |
US11452879B2 (en) | 2007-05-23 | 2022-09-27 | Ebr Systems, Inc. | Optimizing energy transmission in a leadless tissue stimulation system |
US10080903B2 (en) | 2007-05-23 | 2018-09-25 | Ebr Systems, Inc. | Optimizing energy transmission in a leadless tissue stimulation system |
US10456588B2 (en) | 2007-05-23 | 2019-10-29 | Ebr Systems, Inc. | Optimizing energy transmission in a leadless tissue stimulation system |
US8718773B2 (en) | 2007-05-23 | 2014-05-06 | Ebr Systems, Inc. | Optimizing energy transmission in a leadless tissue stimulation system |
US20080294208A1 (en) * | 2007-05-23 | 2008-11-27 | Ebr Systems, Inc. | Optimizing energy transmission in a leadless tissue stimulation system |
US7953493B2 (en) | 2007-12-27 | 2011-05-31 | Ebr Systems, Inc. | Optimizing size of implantable medical devices by isolating the power source |
US9907968B2 (en) | 2008-03-25 | 2018-03-06 | Ebr Systems, Inc. | Temporary electrode connection for wireless pacing systems |
US10688307B2 (en) | 2008-03-25 | 2020-06-23 | Ebr Systems, Inc. | Temporary electrode connection for wireless pacing systems |
US9283392B2 (en) | 2008-03-25 | 2016-03-15 | Ebr Systems, Inc. | Temporary electrode connection for wireless pacing systems |
US11752352B2 (en) | 2008-03-25 | 2023-09-12 | Ebr Systems, Inc. | Temporary electrode connection for wireless pacing systems |
US9731139B2 (en) | 2008-07-16 | 2017-08-15 | Ebr Systems, Inc. | Local lead to improve energy efficiency in implantable wireless acoustic stimulators |
US12023488B2 (en) | 2020-08-17 | 2024-07-02 | Ebr Systems, Inc. | Implantable stimulation assemblies having tissue engagement mechanisms, and associated systems and methods |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3698398A (en) | Rate-scanning pacer for treatment of tachycardia | |
US3693627A (en) | Stimulator for treatment of tachycardia with a burst of stimuli having a continuously variable rate | |
US3478746A (en) | Cardiac implantable demand pacemaker | |
US3595242A (en) | Atrial and ventricular demand pacer | |
US4222386A (en) | Method for stimulating cardiac action by means of implanted _electrocardiostimulator and implantable electrocardiostimulator for effecting same | |
CA1299252C (en) | Implantable cardiac stimulator for detection and treatment of ventricular arrhythmias | |
US4091817A (en) | P-Wave control, R-wave inhibited ventricular stimulation device | |
US4595009A (en) | Protection circuit for implantable cardioverter | |
EP0727241B1 (en) | Device for heart stimulation | |
US6731979B2 (en) | Pulse width cardiac pacing apparatus | |
US7054686B2 (en) | Pulsewidth electrical stimulation | |
US3057356A (en) | Medical cardiac pacemaker | |
US6438418B1 (en) | Method and apparatus for reduction of pain from electric shock therapies | |
ZOLL et al. | Long-term electric pacemakers for Stokes-Adams disease | |
AU769902B2 (en) | Antitachycardial pacing | |
US3669120A (en) | Device for starting or stimulating heart contractions | |
US3757792A (en) | Automatic threshold compensating demand pacemaker | |
US20080046017A1 (en) | Cardiac rhythm management system with staggered pulses for coordination therapy | |
US3344792A (en) | Method of muscular stimulation in human beings to aid in walking | |
ES2326308T3 (en) | PULSE GENERATOR SYSTEM. | |
ZOLL et al. | External and internal electric cardiac pacemakers | |
Quarnstrom | Electronic dental anesthesia | |
US3768486A (en) | Atrial and ventricular demand pacer having wide range atrial escape interval | |
US7155286B1 (en) | System and method for reducing pain associated with cardioversion shocks generated by implantable cardiac stimulation devices | |
IL37845A (en) | Cardiac pacer for providing artificial demand cardiac electrical impulses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: COOK PACEMAKER CORPORATION, INDIANA Free format text: LICENSE;ASSIGNOR:ATLANTIC RICHFIELD COMPANY;REEL/FRAME:003852/0285 Effective date: 19810327 Owner name: COOK PACEMAKER CORPORATION, P.O. BOX 99, BLOOMINGT Free format text: LICENSE;ASSIGNOR:ATLANTIC RICHFIELD COMPANY;REEL/FRAME:003852/0285 Effective date: 19810327 |
|
AS | Assignment |
Owner name: WARNER LAMBERT COMPANY 201 TABOR ROAD, MORRIS PLAI Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:AMERICAN OPTICAL CORPORATION A CORP. OF DE;REEL/FRAME:004054/0502 Effective date: 19820315 |
|
AS | Assignment |
Owner name: TELECTRONICS PTY. LIMITED Free format text: CONFIRMS THE GRANTING OF LICENSE AGREEMENT DATED JULY 1, 1973 SUBJECT TO CONDITIONS IN AGREEMENT DATED JANUARY 16, 1984;ASSIGNOR:HONEYWELL MEDICAL ELECTRONICS B.V.;REEL/FRAME:004436/0297 Effective date: 19850306 |